BRCA2 and cancer: Testing for mutations in high-penetrance cancer predisposition genes, such as BRCA1 or BRCA2, has evolved to an integral part of cancer care because it provides clear information to patients and their families and established guidelines for surveillance with proven benefit exist (http://www.nccn.org).